Display options
Cite
Young MN, Inglessis I. Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations. Curr Treat Options Cardiovasc Med. 2017;19(10):81doi: 10.1007/s11936-017-0580-0.
Young, M. N., & Inglessis, I. (2017). Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations. Current treatment options in cardiovascular medicine, 19(10), 81. https://doi.org/10.1007/s11936-017-0580-0
Young, Michael N, and Inglessis, Ignacio. "Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations." Current treatment options in cardiovascular medicine vol. 19,10 (2017): 81. doi: https://doi.org/10.1007/s11936-017-0580-0
Young MN, Inglessis I. Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations. Curr Treat Options Cardiovasc Med. 2017 Sep 22;19(10):81. doi: 10.1007/s11936-017-0580-0. PMID: 28936594.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Cardiovasc Med. 2017 Sep 22;19(10):81. doi: 10.1007/s11936-017-0580-0.

Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations.

Current treatment options in cardiovascular medicine

Michael N Young, Ignacio Inglessis

Affiliations

  1. Cardiology Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, GRB8-852E, Boston, MA, 02114, USA.
  2. Cardiology Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, GRB8-852E, Boston, MA, 02114, USA. [email protected].

PMID: 28936594 DOI: 10.1007/s11936-017-0580-0

Abstract

OPINION STATEMENT: Transcatheter aortic valve replacement (TAVR) has become the standard of care for the treatment of severe aortic stenosis in individuals who are at prohibitive surgical risk and presents a viable alternative to surgery in selected patients who are at high operative risk. To date, outcomes from the PARTNER (Placement of AoRtic TraNscathetER Valve) and Medtronic CoreValve® US Pivotal trials continue to show the benefits of TAVR in these high-risk subgroups out to 5 and 3 years, respectively (as reported by Mack et al. Lancet. 85:2477-2484 2015; Kapadia et al. Lancet. 385:2485-2491 2015; Deeb et al. J Am Coll Cardiol. 67:2565-2574 2016). Furthermore, the recent release of the PARTNER-2 and SURTAVI trial results among other international data suggest that clinical outcomes for intermediate risk patients may be promising for TAVR compared to surgical aortic valve replacement (SAVR) (as reported by Leon et al. N Engl J Med. 374:1609-1620 2016; Reardon et al. N Engl J Med. 376:1321-1331 2017). However, several questions persist regarding TAVR-specific complications as well as long-term durability. Paravalvular regurgitation, permanent pacemaker implantation, stroke, vascular access injury, and renal failure in post-TAVR patients remain adversaries in the quest to perfect this groundbreaking, game-changing technology (as reported by Khatri et al. Ann Intern Med. 158:35-46 2013). In this review, we provide an up-to-date synopsis of results from landmark clinical trials that cumulatively attest to the comparability of TAVR to best medical therapy and SAVR in extreme-risk, high-risk, and intermediate-risk patient populations. We continue with a review of studies that seek to compare transcatheter vs. surgical valve implantation in lower-risk subgroups. We also introduce ongoing efforts to optimize the peri-procedural management of TAVR and conclude with a presentation of management strategies and new generation valve platforms that seek to address some of the current limitations of transcatheter valve implantation.

Keywords: Aortic stenosis; Transcatheter aortic valve replacement; Transvalvular therapy; Valvular heart disease

References

  1. J Am Coll Cardiol. 2013 Jul 30;62(5):431-8 - PubMed
  2. Catheter Cardiovasc Interv. 2016 Oct;88(4):636-643 - PubMed
  3. Circ Cardiovasc Interv. 2016 Sep;9(9):null - PubMed
  4. J Am Coll Cardiol. 2016 Jun 7;67(22):2565-74 - PubMed
  5. Catheter Cardiovasc Interv. 2007 Nov 1;70(5):760-4 - PubMed
  6. Eur Heart J. 2016 Jul 21;37(28):2226-39 - PubMed
  7. JACC Cardiovasc Interv. 2015 Apr 27;8(5):718-24 - PubMed
  8. JACC Cardiovasc Interv. 2014 Aug;7(8):898-904 - PubMed
  9. J Am Coll Cardiol. 2013 Mar 5;61(9):908-16 - PubMed
  10. J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1036-43 - PubMed
  11. JAMA. 2014 Jul;312(2):162-70 - PubMed
  12. N Engl J Med. 2016 Apr 28;374(17 ):1609-20 - PubMed
  13. Lancet. 2015 Jun 20;385(9986):2485-91 - PubMed
  14. Circ Cardiovasc Interv. 2015 Mar;8(3):e001913 - PubMed
  15. Am J Cardiol. 2014 Feb 1;113(3):518-21 - PubMed
  16. Circ Cardiovasc Interv. 2016 Jun;9(6):null - PubMed
  17. J Am Coll Cardiol. 2012 Apr 3;59(14 ):1287-94 - PubMed
  18. J Am Coll Cardiol. 2015 Aug 18;66(7):791-800 - PubMed
  19. JACC Cardiovasc Interv. 2016 Jan 11;9(1):68-75 - PubMed
  20. Circulation. 1982 Nov;66(5):1105-10 - PubMed
  21. JACC Cardiovasc Interv. 2012 Feb;5(2):121-30 - PubMed
  22. J Am Coll Cardiol. 2016 Sep 13;68(11):1195-1205 - PubMed
  23. Circ Cardiovasc Interv. 2016 Sep;9(9):null - PubMed
  24. J Am Coll Cardiol. 2013 Apr 16;61(15):1585-95 - PubMed
  25. Am J Cardiol. 2012 Sep 15;110(6):877-83 - PubMed
  26. JACC Cardiovasc Interv. 2010 Nov;3(11):1122-5 - PubMed
  27. JACC Cardiovasc Interv. 2015 Dec 21;8(14 ):1777-96 - PubMed
  28. JACC Cardiovasc Interv. 2011 Jul;4(7):721-32 - PubMed
  29. N Engl J Med. 2017 Apr 6;376(14 ):1321-1331 - PubMed
  30. Ann Intern Med. 2013 Jan 1;158(1):35-46 - PubMed
  31. Int J Cardiol. 2014 Oct 20;176(3):1050-2 - PubMed
  32. Am J Cardiol. 2014 Apr 15;113(8):1390-3 - PubMed
  33. J Am Coll Cardiol. 2012 Aug 7;60(6):548-58 - PubMed
  34. Circ J. 2015;79(4):695-703 - PubMed
  35. J Am Coll Cardiol. 2016 Jan 5;67(1):29-38 - PubMed
  36. N Engl J Med. 2012 May 3;366(18):1686-95 - PubMed
  37. Circulation. 2013 Jun 4;127(22):2194-201 - PubMed
  38. N Engl J Med. 2014 May 8;370(19):1790-8 - PubMed
  39. JACC Cardiovasc Interv. 2013 May;6(5):443-51 - PubMed
  40. Eur Heart J. 2015 Aug 14;36(31):2070-2078 - PubMed
  41. N Engl J Med. 2014 May 15;370(20):1920-9 - PubMed
  42. JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-384 - PubMed
  43. N Engl J Med. 2015 Nov 19;373(21):2015-24 - PubMed
  44. JACC Cardiovasc Interv. 2014 Oct;7(10):1146-55 - PubMed
  45. J Am Coll Cardiol. 2015 Aug 18;66(7):804-812 - PubMed
  46. N Engl J Med. 2012 May 3;366(18):1696-704 - PubMed
  47. JACC Cardiovasc Interv. 2012 Dec;5(12):1247-56 - PubMed
  48. Catheter Cardiovasc Interv. 2011 Sep 1;78(3):432-43 - PubMed
  49. JAMA. 2016 Aug 9;316(6):592-601 - PubMed
  50. Int J Cardiol. 2014 Dec 15;177(2):448-54 - PubMed
  51. EuroIntervention. 2016 Feb;11(10 ):1140-7 - PubMed
  52. Circulation. 2009 Aug 4;120(5):e29-30 - PubMed
  53. J Am Coll Cardiol. 2014 Mar 4;63(8):763-8 - PubMed
  54. J Am Soc Echocardiogr. 2011 Sep;24(9):966-75 - PubMed
  55. Trials. 2013 Jan 09;14:11 - PubMed
  56. JACC Cardiovasc Interv. 2015 Aug 24;8(10 ):1359-67 - PubMed
  57. J Am Coll Cardiol. 2015 May 26;65(20):2184-94 - PubMed
  58. Am Heart J. 2012 Dec;164(6):910-7 - PubMed
  59. Lancet. 2015 Jun 20;385(9986):2477-84 - PubMed
  60. Am Heart J. 2012 Apr;163(4):684-9 - PubMed
  61. JACC Cardiovasc Interv. 2008 Jun;1(3):305-9 - PubMed
  62. JACC Cardiovasc Interv. 2016 Apr 25;9(8):817-824 - PubMed
  63. Am J Cardiol. 2014 Sep 1;114(5):757-62 - PubMed
  64. Lancet. 2016 May 28;387(10034):2218-25 - PubMed
  65. JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207-1217 - PubMed
  66. Am Heart J. 2012 Mar;163(3):477-85 - PubMed
  67. J Am Coll Cardiol. 2014 May 20;63(19):1972-81 - PubMed
  68. J Am Coll Cardiol. 2012 Apr 3;59(14 ):1275-86 - PubMed
  69. J Am Coll Cardiol. 2015 Sep 22;66(12 ):1327-34 - PubMed
  70. J Am Coll Cardiol. 2012 Aug 14;60(7):581-6 - PubMed
  71. J Am Coll Cardiol. 2012 Dec 25;60(25):2683-92 - PubMed
  72. J Am Coll Cardiol. 2013 Jul 2;62(1):11-20 - PubMed
  73. Heart Lung Circ. 2014 Nov;23(11):1020-8 - PubMed
  74. JACC Cardiovasc Imaging. 2015 Mar;8(3):261-87 - PubMed
  75. Eur Heart J. 2015 Feb 14;36(7):449-56 - PubMed
  76. Am J Cardiol. 2015 Aug 15;116(4):604-11 - PubMed
  77. Am J Cardiol. 2013 Jan 1;111(1):94-9 - PubMed
  78. JACC Cardiovasc Imaging. 2014 Mar;7(3):319-20 - PubMed
  79. J Am Coll Cardiol. 2015 Jul 14;66(2):113-21 - PubMed
  80. J Am Coll Cardiol. 2012 Mar 27;59(13):1134-41 - PubMed
  81. J Cardiovasc Electrophysiol. 2012 Apr;23(4):391-7 - PubMed
  82. JACC Cardiovasc Interv. 2015 Apr 27;8(5):681-8 - PubMed
  83. EuroIntervention. 2014 Mar 20;9(11):1264-70 - PubMed
  84. Eur Heart J. 2016 Mar 7;37(10 ):803-10 - PubMed
  85. Am J Cardiol. 2016 Apr 15;117(8):1332-8 - PubMed
  86. J Thorac Cardiovasc Surg. 2015 Oct;150(4):833-9 - PubMed
  87. N Engl J Med. 2014 Aug 21;371(8):744-56 - PubMed
  88. JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):60-9 - PubMed
  89. Int J Cardiol. 2013 Sep 1;167(5):1945-52 - PubMed
  90. Circulation. 2014 Mar 18;129(11):1233-43 - PubMed

Publication Types